Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The PreS1 region is an N-terminal domain of the large envelope (L) protein of hepatitis B virus that plays a pivotal role in the viral life cycle and pathogenesis. Composed of approximately 108–119 amino acids (depending on genotype), the PreS1 region is myristoylated at its N-terminus—a modification critical for its fusion and receptor-binding activities. The myristoylated PreS1 domain is exposed on the surface of mature HBV particles, where it directly binds the sodium taurocholate cotransporting polypeptide (NTCP) receptor on hepatocytes, initiating viral entry. Additionally, hydrophobic regions within PreS1 facilitate membrane fusion, function as a fusion peptide, and mediate interactions with the viral capsid during virion maturation. These functions make PreS1 a major target for antiviral drugs and vaccine design, with small molecules and peptide mimics under development to block PreS1-mediated entry. Note: PreS1 itself is not a receptor, enzyme, or transporter, but a viral protein domain acting as a ligand for the human NTCP receptor and mediating membrane fusion, making its classification as a "therapeutic target" accurate in the context of HBV infection therapy.
Competitive inhibition of PreS1 binding to NTCP, blocking viral entry to hepatocytes. Fusion inhibition (preventing membrane fusion and viral uptake).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatitis B virus large envelope protein PreS1 region (PreS1 (context: HBV L protein)).